1,5-anhydrofructose has been researched along with bepridil in 1 studies
*Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. [MeSH]
*Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. [MeSH]
Studies (1,5-anhydrofructose) | Trials (1,5-anhydrofructose) | Recent Studies (post-2010) (1,5-anhydrofructose) | Studies (bepridil) | Trials (bepridil) | Recent Studies (post-2010) (bepridil) |
---|---|---|---|---|---|
41 | 0 | 10 | 798 | 70 | 94 |
Protein | Taxonomy | 1,5-anhydrofructose (IC50) | bepridil (IC50) |
---|---|---|---|
Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 1.4 | |
Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 1 | |
Lethal factor | Bacillus anthracis | 4.8 | |
Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 1 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.5184 | |
Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 1 | |
Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 1.2 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 3.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hizukuri, S; Maruyama, I; Sarker, KP; Yamaji, K | 1 |
1 other study(ies) available for 1,5-anhydrofructose and bepridil
Article | Year |
---|---|
Antioxidant effects of 1,5-anhydro-D-fructose, a new natural sugar, in vitro.
Topics: Antioxidants; Bepridil; Biological Factors; Biphenyl Compounds; Carbohydrates; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Free Radical Scavengers; Free Radicals; Fructose; Humans; Hydrogen Peroxide; Hydroxyl Radical; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Molecular Structure; Monocytes; Picrates; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate | 2002 |